ArticleDrug safety2024

Consensus Guidelines: Best Practices for the Prevention, Detection and Management of Hepatitis B Virus Reactivation in Clinical Trials with Immunosuppressive/Immunomodulatory Therapy.

Eric B Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.